Client News
Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia (TRS) at the 33rd CINP Hybrid World Congress of Neuropsychopharmacology
LINDIS Biotech Announces Online Publication of Abstract on Trifunctional Antibody CATUMAXOMAB for the Treatment of HighRisk Non-Muscle-Invasive Bladder Cancer at the ASCO 2022 Annual Meeting
Abivax phase 2a study results of obefazimod (ABX464) in rheumatoid arthritis published in the journal “Annals of the Rheumatic Diseases” and selected for presentation at EULAR 2022
First subject dosed in Lipigon’s phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical’s LNAplus™ technology platform
Galapagos Biopharma: Vom Labor zum Patienten – vom Start-up zum Biopharmaunternehmen
Destiny Pharma plc: Result of Annual General Meeting and Strategy Update
EsoCap supports first European EoE Day of the European Society of Eosinophilic Oesophagitis on May 22, 2022
Spexis to present at H.C. Wainwright Global Investment Conference
Abivax announces annual ordinary and extraordinary general meeting on June 9, 2022, and the availability of the preparatory documents
